Salute e Benessere

Kanazawa University research: Overcoming cancer drug resistance

Lysosomes perform important biochemical functions. Apart from degrading 'waste' biopolymers, they are involved in cell signaling and energy flow and interact with other organelles. As such, they are also relevant for the development and growth of cancer. Hirao and colleagues first checked whether lysosome activity is an indicator of glioblastoma progression. They looked at glioblastoma cell lines taken from patients and found a correlation between lysosomal activity and glioblastoma…
PR Newswire
02/04/2025

Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal…

TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced dosing has commenced at Johns Hopkins University (JHU) Autoimmunity Center of Excellence, the third clinical site in its Phase 2 trial evaluating intranasal foralumab for the treatment of non-active Secondary Progressive Multiple Sclerosis (na-SPMS). Other active...
Nasdaq GlobeNewswire
02/04/2025

Biogen's Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track…

BiogenInc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to BIIB080, an investigational antisense oligonucleotide (ASO) therapy targeting tau, for the treatment of Alzheimer's disease. Fast Track designation is intended to facilitate the development and expedite the review of investigational drugs that treat serious conditions and address unmet medical needs.“We are encouraged by the FDA's Fast Track designation for...
Nasdaq GlobeNewswire
02/04/2025

Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK…

"By bringing MIC-KEY sales and distribution in-house, we are strengthening our direct relationship with healthcare professionals and patients," said Dieter Krines, Vice President and General Manager, International, Avanos. "This move aligns with our strategy to directly support our customers and ensures we can continue providing trusted, innovative solutions that improve patient care." "By bringing MIC-KEY sales and distribution in-house, we are strengthening our direct…
PR Newswire
02/04/2025

AC Immune Reports Further Positive Interim Results from Phase 2 Trial of…

AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's DiseaseActive immunotherapy with ACI-7104.056 induces high anti-a-synuclein (a-syn) antibody levels on average over 20-fold higher than placebo after 4 immunizationsRepeated immunizations amplify the anti-a-syn antibody response, supporting boostability and the potential to further increase antibody titersACI-7104.056 is well tolerated with no safety issues...
Nasdaq GlobeNewswire
02/04/2025

Helsinn Group submits a new formulation of AKYNZEO® to the European Medicines…

Lugano, Switzerland – April 2, 2025– Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of nearly fifty years of commercial execution and a strong focus in supportive care, oncology and dermato-oncology, today announced the submission of a new formulation for AKYNZEO ®to the European Medicines Agency (EMA).AKYNZEO ®is indicated for the prevention of acute and delayed nausea and vomiting associated with both highly emetogenic cisplatin-based cancer...
Nasdaq GlobeNewswire
02/04/2025

BIOPHARM WINS EXCELLENCE IN GENERIC MEDICINE DEVELOPMENT IN ALGERIA AT THE…

Jay Reddy, CEO of Global Brands Magazine, commented, "We are pleased to honour Biopharm with the Excellence in Generic Medicine Development award in Algeria. This accolade is a testament to their unwavering commitment to innovation, quality, and accessibility in the pharmaceutical industry. It's an honour to celebrate their dedication to improving lives through ground breaking solutions." Jay Reddy, CEO of Global Brands Magazine, commented, "We are pleased to honour Biopharm with…
PR Newswire
02/04/2025

Boehringer Ingelheim reaches more patients in 2024 and prepares new medicine…

Number of patients reached in 2024 jumps 8% to 66 million R&D investments rise to EUR 6.2 billion, 23.2% of group net salesCompany prepares new product launches starting in 2025 Boehringer Ingelheim today announced a continued rise in the number of patients it reached, 66 million in 2024, up 8.0% from the previous year. Development of its current product pipeline is well on track, as the company prepares multiple new product launches, starting in 2025. Research &...
Nasdaq GlobeNewswire
02/04/2025

Arctic Therapeutics research suggests preventative strategy against HCCAA

The research provides insights into the potential of N-acetylcysteine (NAC) as a treatment for HCCAA, a disease with no currently approved therapeutic options. The study highlights how NAC may reduce disease-associated biomarkers and slow disease progression. The research provides insights into the potential of N-acetylcysteine (NAC) as a treatment for HCCAA, a disease with no currently approved therapeutic options. The study highlights how NAC may reduce disease-associated biomarkers and…
PR Newswire
02/04/2025

Duni Group receives EcoVadis Gold Rating and Steps Up Sustainability Efforts

- "We are incredibly proud of the EcoVadis recognition and we continue to strengthen our sustainability efforts to create real impact. This is a testament to the dedication of colleagues across Duni Group. While we celebrate this achievement, we look forward to continue our development and to strive for the Platinum level," says Nermana Bulic, Sustainability Manager at Duni Group. - "We are incredibly proud of the EcoVadis recognition and we continue to strengthen our…
PR Newswire
02/04/2025

CMR Surgical secures more than $200M to accelerate growth

CMR Surgical has closed a financing round of more than $200 million, backed by existing investors and new investor Trinity CapitalThe latest funding will fuel the global commercialisation of its Versius Surgical Robotic System, particularly in the U.S. market, and support continued investment in surgical robotics innovationVersius is the 2nd most adopted soft tissue surgical robot, having been used in over 30,000 surgical procedures worldwide across a wide range of specialties ...
Nasdaq GlobeNewswire
02/04/2025

Accord Healthcare Receives Positive CHMP Opinion for Denosumab, Osvyrti®, and…

Osvyrti® – Bone / Osteoporosis (60mg Pre-Filled Syringe) Osvyrti ®– Bone / Osteoporosis (60mg Pre-Filled Syringe) Jubereq ®– Oncology (120mg Vial) Joe Dunford, Accord's Vice President of Specialty Brands, commented: "At Accord, we are dedicated to transforming patients' lives, and the recent CHMP approval of these vital medicines is a significant milestone. Osvyrti ®enhances our bone health portfolio, joining Sondelbay ®, our previously launched teriparatide biosimilar...
PR Newswire
02/04/2025

Zelluna ASA [ZLNA]: Annual Report 2024

Please find a PDF version of the annual report, as well as the report in European Single Electronic Format (ESEF), as attachments to this release. The Annual Report is also available at the company's website:www.zelluna.com This information is subject to the disclosure requirements pursuant to Section 5-12 in the Norwegian Securities Trading Act. For further information, please contact: Anders Tuv, Chairman of the Board of Directors of Zelluna ASA Email:[email protected]: +47...
Nasdaq GlobeNewswire
02/04/2025

IBA signs contract for a Proteus®ONE solution to be installed at the Tri-Service…

Louvain-La-Neuve, Belgium, April 2 nd, 2025 –IBA(Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract for the supply of a Proteus ® ONE 1compact proton therapy solution to be located at the Tri-Service General Hospital in Taipei, Taiwan. The contract includes the supply of a Proteus ® ONE system and a Quality...
Nasdaq GlobeNewswire
02/04/2025

BioVaxys Technology Corp. Announces Debt Settlement Agreement

All securities proposed to be issued in connection with the Debt Settlement will be subject to a statutory hold period of four months from the date of issuance in accordance with applicable securities legislation. The closing of the Debt Settlement is conditional upon the receipt of all applicable corporate and regulatory approvals, including the acceptance of the Canadian Securities Exchange. All securities proposed to be issued in connection with the Debt Settlement will be subject to a...
PR Newswire
02/04/2025

Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical…

Target enrollment exceeded with 1009 patients randomized in the main cohort and 410 patients in the exploratory cohort Topline results from NATiV3 projected in the second half of 2026 and, if positive, expected to be the basis for submission for regulatory approvalDaix (France), New York City (New York, United States), April 1, 2025 –Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
Nasdaq GlobeNewswire
01/04/2025

Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial…

Company Announcement COPENHAGEN, Denmark; April 1, 2025 –Genmab A/S(Nasdaq: GMAB) – In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) by managerial employees and their closely associated persons. The company's managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to publish...
Nasdaq GlobeNewswire
01/04/2025

Tony's Chocolonely Recalls Batches of 2 Products Due to Potential Presence of…

This recall only affects these specific products and lot codes. All other Tony's Chocolonely products remain safe to consume and are not impacted. This recall only affects these specific products and lot codes. All other Tony's Chocolonely products remain safe to consume and are not impacted. Tony's Chocolonely is working in partnership with retailers and food authorities who are in the process of removing impacted products from sale and distribution. If you have purchased...
PR Newswire
01/04/2025

Valneva's Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged…

With this extension, IXCHIQ ®, the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 years of age and older in the European Union (EU).Saint Herblain (France), April 1, 2025–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Commission (EC) has granted marketing authorization in Europe for Valneva's single-dose vaccine, IXCHIQ ®, for the prevention of disease...
Nasdaq GlobeNewswire
01/04/2025

Availability of the 2024 Universal Registration Document, including the Annual…

Press Release Paris – April 1, 2025– EUROAPI announces the publication of its 2024 Universal Registration Document in ESEF format, filed with the FrenchAutorité des marchés financiers(AMF) on April 1, 2025.The 2024 Universal Registration Document contains in particular: The annual financial report, including the management report that encompasses namely the Corporate Governance report, the sustainability statement and the company and consolidated statements;The...
Nasdaq GlobeNewswire
01/04/2025

Annual General Meeting of AB SKF

The Board members and the CEO were discharged from liability for their administration of the company for the financial year 2024. The Board members and the CEO were discharged from liability for their administration of the company for the financial year 2024. Hans Stråberg, Hock Goh,Geert Follens, Håkan Buskhe,Susanna Schneeberger,Rickard Gustafson,Beth Ferreira,Therese Friberg,Richard Nilssonand Niko Pakalén were reelected as Board members. Mats Rahmström was newly...
PR Newswire
01/04/2025

US Single-use Assemblies Market worth US$1658.8 million by 2029 with 15.0% CAGR…

Browse in-depth TOC on "US Single-use Assemblies Market" Browse in-depth TOC on "US Single-use Assemblies Market" 154 - Tables 50 – Figures The filtration & purification segment accounted for the largest share of the application segment in the US single-use assemblies market in 2023. Based on Application, The US single-use assemblies services market is segmented into filtration & purification applications, aseptic transfer, storage applications, sampling...
PR Newswire
01/04/2025

Coffee Machine Market Surges to USD 6.15 Billion by 2033, Propelled by 5.0% CAGR…

Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=43824 Download PDF Brochure:https://www.verifiedmarketreports.com/download-sample/?rid=43824 Browse in-depth TOC on Coffee Machine Market 202 - Pages 126 – Tables 37 – Figures Scope of The Report Global Coffee Machine Market Overview Key Market Drivers Fueling Growth in the Coffee Machine Market 1. Surging Consumer Demand for Specialty Coffee The coffee machine market...
PR Newswire
01/04/2025

High Content Screening Market worth US$2.19 billion in 2030 with 7.5% CAGR |…

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=42710391 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=42710391 Browse in-depth TOC on "High Content Screening Market" 363 - Tables 31 - Figures 358 - Pages By Based on cell detection and analysis system segment,the market is segmented by instrument into high content imaging platforms, cell detection and analysis systems, and cell imaging systems. The high...
PR Newswire
01/04/2025
Altri  Comunicati